Clinical Trials
4 trialsNCT06384222 2025-12-30
Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone
University of California, San Francisco
Phase 2 Recruiting
NCT02913131 2022-04-22
Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor Malignancies
University of California, San Francisco
Phase 1/2 Terminated
NCT02911467 2020-07-24
MR
University of California, San Francisco
Phase 1 Terminated
NCT02450201 2018-10-23
MRI With C13 Pilot Study Prostate Cancer
University of California, San Francisco
Phase EARLY_PHASE1 Terminated